Proteomic, genomic and translational approaches identify CRMP1 for a role in schizophrenia and its underlying traits

Human Molecular Genetics

Volumn 21, Issue 20, 2012, Pages 4406-4418

  Bader, Verian ^a   Tomppo, Liisa ^b   Trossbach, Svenja V ^a   Bradshaw, Nicholas J ^a   Prikulis, Ingrid ^a   Rutger Leliveld, S ^a   Lin, Chi Ying ^c   Ishizuka, Koko ^c   Sawa, Akira ^c   Ramos, Adriana ^d   Rosa, Isaac ^d   García, Ångel ^d   Requena, Jesús R ^d   Hipolito, Maria ^e   Rai, Narayan ^e   Nwulia, Evaristus ^e   Henning, Uwe ^a   Ferrea, Stefano ^a   Luckhaus, Christian ^a   Ekelund, Jesper ^b,f,g   Veijola, Juha ^h   Järvelin, Marjo Riitta ^i,j   Hennah, William ^b,f,k   Korth, Carsten ^a   more..

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF HELSINKI   (Finland)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^e HOWARD UNIVERSITY   (United States)

^f NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^g VAASA HOSPITAL DISTRICT   (Finland)

^h OULU UNIVERSITY HOSPITAL   (Finland)

ⁱ PUBLIC HEALTH ENGLAND   (United Kingdom)

^j UNIVERSITY OF OULU   (Finland)

^k UNIVERSITY OF EDINBURGH   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANHEDONIA; ANIMAL TISSUE; ARTICLE; COLLAPSIN RESPONSE MEDIATOR PROTEIN 1 GENE; CONTROLLED STUDY; DISRUPTED IN SCHIZOPHRENIA 1 GENE; GENE; GENETIC ASSOCIATION; GENOMICS; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LYMPHOBLAST; MENTAL DISEASE; MOUSE; NONHUMAN; POPULATION GENETICS; PRIORITY JOURNAL; PROTEOMICS; SCHIZOPHRENIA;

ADULT; ANIMALS; BRAIN; CELL LINE, TUMOR; COHORT STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; MICE; NERVE TISSUE PROTEINS; PROTEOME; PROTEOMICS; SCHIZOPHRENIA; TRANSFECTION;

EID: 84867118143     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds273     Document Type: Article

References (76)

1. Freimer, N. and Sabatti, C. (2003) The human phenome project. Nat. Genet., 34, 15-21.
2. Gottesman, I.I. and Gould, T.D. (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry, 160, 636-645.
3. Fanous, A., Gardner, C., Walsh, D. and Kendler, K.S. (2001) Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in nonpsychotic relatives. Arch. Gen. Psychiatry, 58, 669-673.
4. Vollema, M.G., Sitskoorn, M.M., Appels, M.C. and Kahn, R.S. (2002) Does the Schizotypal Personality Questionnaire reflect the biological-genetic vulnerability to schizophrenia? Schizophr. Res., 54, 39-45.
5. Kendler, K.S., McGuire, M., Gruenberg, A.M., O'Hare, A., Spellman, M. and Walsh, D. (1993) The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch. Gen. Psychiatry, 50, 527-540.
6. Kendler, K.S., McGuire, M., Gruenberg, A.M., O'Hare, A., Spellman, M. and Walsh, D. (1993) The Roscommon Family Study. III. Schizophrenia-related personality disorders in relatives. Arch. Gen. Psychiatry, 50, 781-788.
7. Powell, S.B., Zhou, X. and Geyer, M.A. (2009) Prepulse inhibition and genetic mouse models of schizophrenia. Behav. Brain Res., 204, 282-294.
8. Der-Avakian, A. and Markou, A. (2012) The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci., 35, 68-77.
9. American Psychiatric Association (1994) Diagnostic and Statistical Manual IV (DSM IV). American Psychiatric Association, Washington, DC.
10. Van der Heiden, W. and Hafner, H. (2000) The epidemiology of onset and course of schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci., 250, 292-303.
11. Kirkpatrick, B., Buchanan, R.W., Ross, D.E. and Carpenter, W.T. Jr. (2001) A separate disease within the syndrome of schizophrenia. Arch. Gen. Psychiatry, 58, 165-171.
12. Owen, M.J., Craddock, N. and Jablensky, A. (2007) The genetic deconstruction of psychosis. Schizophr. Bull., 33, 905-911.
13. Berrettini, W. (2003) Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am. J. Med. Genet., 123, 59-64.
14. Horan, W.P., Reise, S.P., Subotnik, K.L., Ventura, J. and Nuechterlein, K.H. (2008) The validity of Psychosis Proneness Scales as vulnerability indicators in recent-onset schizophrenia patients. Schizophr. Res., 100, 224-236.
15. Millar, J.K., Wilson-Annan, J.C., Anderson, S., Christie, S., Taylor, M.S., Semple, C.A., Devon, R.S., Clair, D.M., Muir, W.J., Blackwood, D.H. et al. (2000) Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum. Mol. Genet., 9, 1415-1423.
16. Hennah, W., Varilo, T., Kestila, M., Paunio, T., Arajarvi, R., Haukka, J., Parker, A., Martin, R., Levitzky, S., Partonen, T. et al. (2003) Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum. Mol. Genet., 12, 3151-3159.
17. Ekelund, J., Hovatta, I., Parker, A., Paunio, T., Varilo, T., Martin, R., Suhonen, J., Ellonen, P., Chan, G., Sinsheimer, J.S. et al. (2001) Chromosome 1 loci in Finnish schizophrenia families. Hum. Mol. Genet., 10, 1611-1617.
18. Tomppo, L., Hennah, W., Miettunen, J., Jarvelin, M.R., Veijola, J., Ripatti, S., Lahermo, P., Lichtermann, D., Peltonen, L. and Ekelund, J. (2009) Association of variants in DISC1 with psychosis-related traits in a large population cohort. Arch. Gen. Psychiatry, 66, 134-141.
19. Hikida, T., Jaaro-Peled, H., Seshadri, S., Oishi, K., Hookway, C., Kong, S., Wu, D., Xue, R., Andrade, M., Tankou, S. et al. (2007) Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans. Proc. Natl Acad. Sci. USA, 104, 14501-14506.
20. Clapcote, S.J., Lipina, T.V., Millar, J.K., Mackie, S., Christie, S., Ogawa, F., Lerch, J.P., Trimble, K., Uchiyama, M., Sakuraba, Y. et al. (2007) Behavioral phenotypes of Disc1 missense mutations in mice. Neuron, 54, 387-402.
21. Shen, S., Lang, B., Nakamoto, C., Zhang, F., Pu, J., Kuan, S.L., Chatzi, C., He, S., Mackie, I., Brandon, N.J. et al. (2008) Schizophrenia-related neural and behavioral phenotypes in transgenic mice expressing truncated Disc1. J. Neurosci., 28, 10893-10904.
22. Cryan, J.F. and Mombereau, C. (2004) In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol. Psychiatry, 9, 326-357.
23. Brandon, N.J., Millar, J.K., Korth, C., Sive, H., Singh, K.K. and Sawa, A. (2009) Understanding the role of DISC1 in psychiatric disease and during normal development. J. Neurosci., 29, 12768-12775.
24. Brandon, N.J. and Sawa, A. (2011) Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat. Rev. Neurosci., 12, 707-722.
25. Mathieson, I., Munafo, M.R. and Flint, J. (2011) Meta-analysis indicates that common variants at the DISC1 locus are not associated with schizophrenia. Mol. Psychiatry, 16, 1-8.
26. Bertram, L., Lill, C.M. and Tanzi, R.E. (2010) The genetics of Alzheimer disease: back to the future. Neuron, 68, 270-281.
27. Chua, S.E. and McKenna, P.J. (2000) A sceptical view of the neuropathology of Schizophrenia. In Harrison, P.J. and Roberts, G.W. (eds), The Neuropathology of Schizophrenia. Oxford University Press, Oxford, pp. 291-338.
28. Kirkpatrick, B., Fenton, W.S., Carpenter, W.T. Jr. and Marder, S.R. (2006) The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull., 32, 214-219.
29. van Haren, N.E., Cahn, W., Hulshoff Pol, H.E. and Kahn, R.S. (2008) Schizophrenia as a progressive brain disease. Eur. Psychiatry, 23, 245-254.
30. Powers, E.T., Morimoto, R.I., Dillin, A., Kelly, J.W. and Balch, W.E. (2009) Biological and chemical approaches to diseases of proteostasis deficiency. Ann. Rev. Biochem., 78, 959-991.
31. Leliveld, S.R., Bader, V., Hendriks, P., Prikulis, I., Sajnani, G., Requena, J.R. and Korth, C. (2008) Insolubility of disrupted-in-schizophrenia 1 disrupts oligomer-dependent interactions with nuclear distribution element 1 and is associated with sporadic mental disease. J. Neurosci., 28, 3839-3845.
32. Seshadri, S., Kamiya, A., Yokota, Y., Prikulis, I., Kano, S., Hayashi-Takagi, A., Stanco, A., Eom, T.Y., Rao, S., Ishizuka, K. et al. (2010) Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc. Natl Acad. Sci. USA, 107, 5622-5627.
33. Young-Pearse, T.L., Suth, S., Luth, E.S., Sawa, A. and Selkoe, D.J. (2010) Biochemical and functional interaction of disrupted-in-schizophrenia 1 and amyloid precursor protein regulates neuronal migration during mammalian cortical development. J. Neurosci., 30, 10431-10440.
34. Ottis, P., Bader, V., Trossbach, S., Kretzschmar, H., Michel, M., Leliveld, S.R. and Korth, C. (2011) Convergence of two independent mental disease genes on the protein level: recruitment of dysbindin to cell invasive DISC1 aggresomes. Biol. Psychiatry, 70, 604-610.
35. Atkin, T.A., Brandon, N.J. and Kittler, J.T. (2012) Disrupted in Schizophrenia 1 forms pathological aggresomes that disrupt its function in intracellular transport. Hum. Mol. Genet., 21, 2017-2028.
36. Torrey, E.F., Webster, M., Knable, M., Johnston, N. and Yolken, R.H. (2000) The Stanley Foundation Brain Collection And Neuropathology Consortium. Schizophr. Res., 44, 151-155.
37. Kohler, G. and Milstein, C. (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature, 256, 495-497.
38. Korth, C., Stierli, B., Streit, P., Moser, M., Schaller, O., Fischer, R., Schulz-Schaeffer, W., Kretzschmar, H., Raeber, A., Braun, U. et al. (1997) Prion (PrPSc)-specific epitope defined by a monoclonal antibody. Nature, 389, 74-77.
39. Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K. et al. (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature, 400, 173-177.
40. Masliah, E., Rockenstein, E., Adame, A., Alford, M., Crews, L., Hashimoto, M., Seubert, P., Lee, M., Goldstein, J., Chilcote, T. et al. (2005) Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease. Neuron, 46, 857-868.
41. Korth, C., Streit, P. and Oesch, B. (1999) Monoclonal antibodies specific for the native, disease-associated isoform of the prion protein. Methods Enzymol., 309, 102-112.
42. Bussow, K., Nordhoff, E., Lubbert, C., Lehrach, H. and Walter, G. (2000) A human cDNA library for high-throughput protein expression screening. Genomics, 65, 1-8.
43. Eisen, H.N. and Chakraborty, A.K. (2010) Evolving concepts of specificity in immune reactions. Proc. Natl Acad. Sci. USA, 107, 22373-22380.
44. Chubb, J.E., Bradshaw, N.J., Soares, D.C., Porteous, D.J. and Millar, J.K. (2008) The DISC locus in psychiatric illness. Mol. Psychiatry, 13, 36-64.
45. Yuasa-Kawada, J., Suzuki, R., Kano, F., Ohkawara, T., Murata, M. and Noda, M. (2003) Axonal morphogenesis controlled by antagonistic roles of two CRMP subtypes in microtubule organization. Eur. J. Neurosci., 17, 2329-2343.
46. Jiang, S.X., Kappler, J., Zurakowski, B., Desbois, A., Aylsworth, A. and Hou, S.T. (2007) Calpain cleavage of collapsin response mediator proteins in ischemic mouse brain. Eur. J. Neurosci., 26, 801-809.
47. Leliveld, S.R., Hendriks, P., Michel, M., Sajnani, G., Bader, V., Trossbach, S., Prikulis, I., Hartmann, R., Jonas, E., Willbold, D. et al. (2009) Oligomer assembly of the C-terminal DISC1 domain (640-854) is controlled by self-association motifs and disease-associated polymorphism S704C. Biochemistry, 48, 7746-7755.
48. Pan, S.H., Chao, Y.C., Hung, P.F., Chen, H.Y., Yang, S.C., Chang, Y.L., Wu, C.T., Chang, C.C., Wang, W.L., Chan, W.K. et al. (2011) The ability of LCRMP-1 to promote cancer invasion by enhancing filopodia formation is antagonized by CRMP-1. J. Clin. Invest., 121, 3189-3205.
49. Tomppo, L. (2010) The DISC1 pathway in the genetic etiology of schizophrenia. PhD Thesis, Department of Medical Genetics, University of Helsinki, Helsinki, 108 pp.
50. Mouquet, H. and Nussenzweig, M.C. (2012) Polyreactive antibodies in adaptive immune responses to viruses. Cell. Mol. Life Sci., 69, 1435-1445.
51. Goshima, Y., Nakamura, F., Strittmatter, P. and Strittmatter, S.M. (1995) Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature, 376, 509-514.
52. Yamashita, N., Uchida, Y., Ohshima, T., Hirai, S., Nakamura, F., Taniguchi, M., Mikoshiba, K., Honnorat, J., Kolattukudy, P., Thomasset, N. et al. (2006) Collapsin response mediator protein 1 mediates reelin signaling in cortical neuronal migration. J. Neurosci., 26, 13357-13362.
53. Hensley, K., Venkova, K., Christov, A., Gunning, W. and Park, J. (2011) Collapsin response mediator protein-2: an emerging pathologic feature and therapeutic target for neurodisease indications. Mol. Neurobiol., 43, 180-191.
54. Lin, P.C., Chan, P.M., Hall, C. and Manser, E. (2011) CRMPs are a new class of MAP that selectively interact with assembled microtubules via a taxol-sensitive binding interaction. J. Biol. Chem., 286, 41466-41478.
55. Shen, Y., Li, N., Wu, S., Zhou, Y., Shan, Y., Zhang, Q., Ding, C., Yuan, Q., Zhao, F., Zeng, R. et al. (2008) Nudel binds Cdc42GAP to modulate Cdc42 activity at the leading edge of migrating cells. Dev. Cell, 14, 342-353.
56. Leemhuis, J., Bouche, E., Frotscher, M., Henle, F., Hein, L., Herz, J., Meyer, D.K., Pichler, M., Roth, G., Schwan, C. et al. (2010) Reelin signals through apolipoprotein E receptor 2 and Cdc42 to increase growth cone motility and filopodia formation. J. Neurosci., 30, 14759-14772.
57. Brandon, N.J., Handford, E.J., Schurov, I., Rain, J.C., Pelling, M., Duran-Jimeniz, B., Camargo, L.M., Oliver, K.R., Beher, D., Shearman, M.S. et al. (2004) Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders. Mol. Cell. Neurosci., 25, 42-55.
58. Jaaro-Peled, H., Hayashi-Takagi, A., Seshadri, S., Kamiya, A., Brandon, N.J. and Sawa, A. (2009) Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends Neurosci., 32, 485-495.
59. Hennah, W. and Porteous, D. (2009) The DISC1 pathway modulates expression of neurodevelopmental, synaptogenic and sensory perception genes. PloS One, 4, e4906.
60. Underhill, G.H., George, D., Bremer, E.G. and Kansas, G.S. (2003) Gene expression profiling reveals a highly specialized genetic program of plasma cells. Blood, 101, 4013-4021.
61. Knuesel, I. (2010) Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases. Prog. Neurobiol., 91, 257-274.
62. Fatemi, S.H. (2005) Reelin glycoprotein: structure, biology and roles in health and disease. Mol. Psychiatry, 10, 251-257.
63. Narr, K.L., Toga, A.W., Szeszko, P., Thompson, P.M., Woods, R.P., Robinson, D., Sevy, S., Wang, Y., Schrock, K. and Bilder, R.M. (2005) Cortical thinning in cingulate and occipital cortices in first episode schizophrenia. Biol. Psychiatry, 58, 32-40.
64. Korth, C., Kaneko, K. and Prusiner, S.B. (2000) Expression of unglycosylated mutated prion protein facilitates PrPSc formation in neuroblastoma cells infected with different prion strains. J. Gen. Virol., 81, 2555-2563.
65. Kamiya, A., Kubo, K., Tomoda, T., Takaki, M., Youn, R., Ozeki, Y., Sawamura, N., Park, U., Kudo, C., Okawa, M. et al. (2005) A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat. Cell Biol., 7, 1167-1178.
66. Chapman, L.J., Chapman, J.P. and Raulin, M.L. (1976) Scales for physical and social anhedonia. J. Abnorm. Psychol., 85, 374-382.
67. Golden, R.R. and Meehl, P.E. (1979) Detection of the schizoid taxon with MMPI indicators. J. Abnorm. Psychol., 88, 217-233.
68. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
69. Nyholt, D.R. (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet., 74, 765-769.
70. Li, J. and Ji, L. (2005) Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity, 95, 221-227.
71. Hennah, W., Thomson, P., McQuillin, A., Bass, N., Loukola, A., Anjorin, A., Blackwood, D., Curtis, D., Deary, I.J., Harris, S.E. et al. (2009) DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder. Mol. Psychiatry, 14, 865-873.
72. Tomppo, L., Hennah, W., Lahermo, P., Loukola, A., Tuulio-Henriksson, A., Suvisaari, J., Partonen, T., Ekelund, J., Lonnqvist, J. and Peltonen, L. (2009) Association between genes of Disrupted in schizophrenia 1 (DISC1) interactors and schizophrenia supports the role of the DISC1 pathway in the etiology of major mental illnesses. Biol. Psychiatry, 65, 1055-1062.
73. Sawa, A., Wiegand, G.W., Cooper, J., Margolis, R.L., Sharp, A.H., Lawler, J.F. Jr, Greenamyre, J.T., Snyder, S.H. and Ross, C.A. (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat. Med., 5, 1194-1198.
74. Penno, M.B., Pedrotti-Krueger, M. and Ray, T. (1993) Cryopreservation of whole blood and isolated lymphocytes for B-cell immortalization. J. Tiss. Cult. Meth., 15, 43-48.
75. Neitzel, H. (1986) A routine method for the establishment of permanent growing lymphoblastoid cell lines. Hum. Genet., 73, 320-326.
76. Wang, Q., Charych, E.I., Pulito, V.L., Lee, J.B., Graziane, N.M., Crozier, R.A., Revilla-Sanchez, R., Kelly, M.P., Dunlop, A.J., Murdoch, H. et al. (2011) The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function. Mol. Psychiatry, 16.